If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
ESMO20 YO for YO: Highlights on metastatic NSCLC-Keynote 024 update
In this podcast, Dr Elene Mariamidze (a member of the ESMO Young Oncologists Committee) interviews Dr Laura Mezquita (Thoracic Oncology Group) regarding novelties presented on ESMO 2020 in the field of metastatic NSCLC.
ESMO20 YO for YO: Highlights on adjuvant CDK4/6 inhibitors in early HR+/HER2- breast cancer
Drs Alexios Matikas and Matteo Lambertini discuss the results of two major randomized trials, presented at the ESMO Virtual Congress 2020, on the adjuvant use of cyclin dependent kinase 4/6 inhibitors (CDK4/6i) for early hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer (BC).
ESMO Open is the European Society for Medical Oncology's online-only, peer-reviewed open access journal, dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research.
Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
Immuno-Oncology and Technology (IOTECH) is sister journal to Annals of Oncology and ESMO Open and the most recent addition to the European Society for Medical Oncology’s portfolio of world-class journals. By publishing high quality original research articles, reviews, perspectives, technology explained papers, letters to the editor and editorials, IOTECH aspires to provide a forum for todays’ leaders in the field of Immuno-Oncology.
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information.